Total Funding
23
38
Total FundingPost-IPO Equity raised
Growth Score
-1 pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
157887
Liminal is a biopharmaceutical corporation supplying state-of-the-art technologies for bio-separations as well as therapeutic products.
- Bruce Pritchard: COO - InternationalPast Role: Liminal BioSciences, CFO of the Group
- Past Role: Syncona Partners LLP, Executive Partner
About the Company
Liminal BioSciences is a biopharmaceutical corporation supplying state-of-the-art technologies for bio-separations as well as therapeutic products. It specializes in discovering, developing, and commercializing novel small molecule compounds for respiratory, liver, and renal diseases. The company focuses specifically on developing solutions for
rare and orphan diseases.
Liminal BioSciences was founded in 1992 and is headquartered in Laval, Quebec.
